Search for: "REDDY PHARMACEUTICALS, INC."
Results 1 - 20
of 96
Sort by Relevance
|
Sort by Date
8 Nov 2023, 4:15 am
Sandoz Inc., 678 F. 3d 1280, 1289 (Fed. [read post]
8 Nov 2023, 4:15 am
Sandoz Inc., 678 F. 3d 1280, 1289 (Fed. [read post]
30 Nov 2021, 9:36 am
Reddy’s Labs (Fed. [read post]
20 Oct 2021, 6:11 am
CytoDyn Inc., C.A. [read post]
20 Jan 2021, 12:58 pm
Reddy’s Laboratories Inc., may not be relevant to any other case, but it caught my attention as an example of the perils of claim drafting. [read post]
8 Dec 2020, 1:00 pm
Instead, the ANDA applicants must simply prove that their proposed generic product is bioequivalent of an existing pharmaceutical, often called the innovator drug. [read post]
3 Sep 2020, 9:23 pm
Reddy's Laboratories, Inc., and Dr. [read post]
30 Jun 2020, 6:59 am
Reddy’s Labs., Ltd. [read post]
16 Jun 2020, 9:59 pm
Reddy's Laboratories, S.A.). [read post]
30 Mar 2020, 10:00 pm
Hikma Pharmaceuticals USA Inc., regarding the validity of six patents owned by Amarin Pharmaceuticals for the drug Vascepa. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
13 Jan 2020, 7:55 am
Apple Inc., et al., No. 19-591 (due process and R.36 affirmances) Nuvo Pharmaceuticals, et al. v. [read post]
27 Aug 2019, 2:03 am
Reddy’s Laboratories Inc., which seemed to impose a higher standard for satisfying the written description requirement, the Federal Circuit decision in Nalpropion Pharmaceuticals, Inc. v. [read post]
24 Jul 2019, 10:03 am
Reddy’s Laboratories Inc., Docket No. 17-02473 (Fed. [read post]
4 Jun 2019, 4:12 am
Reddy’s Laboratories Inc., the Federal Circuit reversed the district court and found the asserted patents invalid for failing to satisfy the written description requirement. [read post]
23 May 2019, 10:47 am
In Nuvo Pharmaceuticals Designated Activity Co. v Reddy’s Laboratories Inc., 2019 U.S. [read post]
21 May 2019, 9:59 pm
By Kevin E. [read post]
31 Jan 2019, 8:32 am
Reddy’s Labs. [read post]
1 Jan 2019, 5:10 pm
In 2017, the Department filed suit against UnitedHealth Group Inc. [read post]
7 Dec 2018, 2:15 am
Reddy’s Laboratories, S.A., which vacated a preliminary injunction handed out by the District of New Jersey in a Hatch-Waxman patent infringement case brought by British pharmaceutical firm Indivior. [read post]
